Cargando…
Ozanimod: A Review in Ulcerative Colitis
Ozanimod (Zeposia(®)) is the first sphingosine-1-phosphate receptor (S1PR) modulator to be approved for the treatment of adults with moderately to severely active ulcerative colitis in the USA, and in adults with moderately to severely active ulcerative colitis who have had an inadequate or lost res...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499884/ https://www.ncbi.nlm.nih.gov/pubmed/35994200 http://dx.doi.org/10.1007/s40265-022-01762-8 |